Role of FDG (18F) PET in paraneoplastic neurological syndromes

被引：1

作者：

Daragon, N. ^{[1
]}

Desarnaud, S. ^{[1
]}

Kas, A. ^{[1
]}

Maksud, P. ^{[1
]}

Houzard, C. ^{[2
]}

Pina-Jomir, G. ^{[3
]}

Farid, K. ^{[4
]}

Abulizi, M. ^{[1
]}

Habert, M. -O. ^{[1
]}

机构：

[1] Grp Hosp Pitie Salpetriere, Nucl Med Serv, F-75651 Paris 13, France

[2] CHU Lyon Sud, Nucl Med Serv, F-69495 Pierre Benite, France

[3] CHU Lyon Pole Est, Ctr Med Nucl, F-69677 Bron, France

[4] Hop Hotel Dieu, Nucl Med Serv, F-75181 Paris 04, France

来源：

MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE | 2010年 / 34卷 / 07期

关键词：

FDG PET; Paraneoplastic neurological syndromes; RECOMMENDED DIAGNOSTIC-CRITERIA; POSITRON-EMISSION-TOMOGRAPHY; TUMOR; MALIGNANCY; MANAGEMENT; MRI;

D O I：

10.1016/j.mednuc.2010.05.008

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Paraneoplastic neurological syndromes (PNS) are rare non-metastatic manifestations of cancer. However, in this family of diseases, to recognize the underlying malignancy is an emergency. The ultimate aim is to treat the patient and try to stabilize or improve the neurological dysfunction, which is frequently the cause of the patient's death. The yield of FDG PET seems to be poor in unselected PNS. In the last decade, neurologists have attempted to provide more rigorous diagnostic criteria for PNS. Thus, "classical" PNS and a panel of "well-characterized" onconeural antibodies have been defined in order to facilitate triage of patients for whom FDG PET would be more sensitive. Currently, given the limited availability of PET cameras in France, this examination should be performed in the presence of either a "classical" PNS with or without onconeuralantibodies positivity or other PNS with onconeural antibodies positivity. The FOG PET should be triggered after a negative conventional imasing work up. (C) 2010 Elsevier Masson SAS. All rights reserved.

引用

页码：399 / 405

页数：7

共 21 条

[11] Recommended diagnostic criteria for paraneoplastic neurological syndromes [J].

Greenlee, JE .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (08) :1090-1090

[12] PET scan in clinically suspected paraneoplastic neurological syndromes: a 6-year prospective study in a regional neuroscience unit [J].

Hadjivassiliou, M. ;

Alder, S. J. ;

Van Beek, E. J. R. ;

Hanney, M. B. ;

Lorenz, E. ;

Rao, D. G. ;

Sharrack, B. ;

Tindale, W. B. .

ACTA NEUROLOGICA SCANDINAVICA, 2009, 119 (03) :186-193

[13] Which role of antineural autoantibodies in central nervous system diseases? [J].

Honnorat, J. .

REVUE NEUROLOGIQUE, 2008, 164 (05) :403-404

[14] Antibody-positive paraneoplastic neurologic syndromes - Value of CT and PET for tumor diagnosis [J].

Linke, R ;

Schroeder, M ;

Helmberger, T ;

Voltz, R .

NEUROLOGY, 2004, 63 (02) :282-286

[15] Paraneoplastic and oncologic profiles of patients seropositive for type 1 antineuronal nuclear autoantibodies [J].

Lucchinetti, CF ;

Kimmel, DW ;

Lennon, VA .

NEUROLOGY, 1998, 50 (03) :652-657

[16] Orchiectomy for suspected microscopic tumor in patients with anti-Ma2-associated encephalitis [J].

Mathew, R. M. ;

Vandenberghe, R. ;

Garcia-Merino, A. ;

Yamamoto, T. ;

Landolfi, J. C. ;

Rosenfeld, M. R. ;

Rossi, J. E. ;

Thiessen, B. ;

Dropcho, E. J. ;

Dalmau, J. .

NEUROLOGY, 2007, 68 (12) :900-905

[17]

Patel RR, 2008, MAYO CLIN PROC, V83, P917, DOI 10.4065/83.8.917

[18] Long-term outcome in children with opsoclonus-myoclonus associated with localized neuroblastoma: a report from the French Society of Pediatric Oncology [J].

Plantaz, D ;

Michon, J ;

Valteau-Couanet, D ;

Coze, C ;

Chastagner, P ;

Bergeron, C ;

Nelken, B ;

Martelli, H ;

Peyroulet, MC ;

Carpentier, AF ;

Armari-Alla, C ;

Pagnier, A ;

Rubie, H .

ARCHIVES DE PEDIATRIE, 2000, 7 (06) :621-628

[19] The role of [18F]fluoro-2-deoxyglucose-PET scanning in the diagnosis of paraneoplastic neurological disorders [J].

Rees, JH ;

Hain, SF ;

Johnson, MR ;

Hughes, RAC ;

Costa, DC ;

Ell, PJ ;

Keir, G ;

Rudge, P .

BRAIN, 2001, 124 :2223-2231

[20] Management of paraneoplastic neurological syndromes: report of an EFNS Task Force [J].

Vedeler, C. A. ;

Antoine, J. C. ;

Giometto, B. ;

Graus, F. ;

Grisold, W. ;

Hart, I. K. ;

Honnorat, J. ;

Smitt, P. A. E. Sillevis ;

Verschuuren, J. J. G. M. ;

Voltz, R. .

EUROPEAN JOURNAL OF NEUROLOGY, 2006, 13 (07) :682-690

← 1 2 3 →